Filing Details
- Accession Number:
- 0001181431-12-018147
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-03-16 21:33:48
- Reporting Period:
- 2012-03-14
- Filing Date:
- 2012-03-16
- Accepted Time:
- 2012-03-16 20:33:48
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1361103 | Complete Genomics Inc | GNOM | Services-Commercial Physical & Biological Research (8731) | 203226545 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1134570 | Jr P Charles Waite | C/O Ovp Venture Partners 1010 Market Street Kirkland WA 98033 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.001 | Disposition | 2012-03-14 | 142,941 | $3.09 | 2,007,609 | No | 4 | S | Indirect | See Footnote |
Common Stock, Par Value $0.001 | Disposition | 2012-03-15 | 165,059 | $2.89 | 1,842,550 | No | 4 | S | Indirect | See Footnote |
Common Stock, Par Value $0.001 | Disposition | 2012-03-16 | 450,000 | $2.92 | 1,392,550 | No | 4 | S | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See Footnote |
No | 4 | S | Indirect | See Footnote |
No | 4 | S | Indirect | See Footnote |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock, Par Value $0.001 | 32,079 | Indirect | See Footnote |
Common Stock, Par Value $0.001 | 1,666 | Direct |
Footnotes
- The transaction was executed in multiple trades in prices ranging from $3.05 to $3.22, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- The transaction was executed in multiple trades in prices ranging from $2.86 to $3.06, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- The transaction was executed in multiple trades in prices ranging from $2.80 to $2.99, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.
- The shares are owned by OVP Venture Partners VI, L.P. (OVP VI"). OVMC VI, LLC ("OVMC VI LLC") serves as the general partner of OVP VI. Charles P. Waite, Jr. is a managing member of OVMC VI LLC and shares voting and investment power over the shares held by OVP VI. The Reporting Person disclaims beneficial ownership of the shares reported herein, except to the extent of his proportionate pecuniary interest therein.
- The shares are owned by OVP VI Entrepreneurs Fund, L.P. ("OVP VI Entrepreneurs"). OVMC VI LLC serves as the general partner of OVP VI Entrepreneurs. Charles P. Waite, Jr. is a managing member of OVMC VI LLC and shares voting and investment power over the shares held by OVP VI Entrepreneurs. The Reporting Person disclaims beneficial ownership of the shares reported herein, except to the extent of his proportionate pecuniary interest therein.